BPA Call VA24513A0007-VA24514F0158

BD Biosciences has been awarded a firm fixed price delivery order against their Multiple Award Schedule contract with GSA for an annual service contract on a BD FACSCanto II flow cytometry system. The $12,981.60 contract has a completion date of December 26, 2024 and was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases on December 27, 2023. The place of performance is San Jose, California. No set-aside designation was used for this contract....

This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 2 (VISN2), which is part of the U.S. Department of Veterans Affairs (VA), to Becton, Dickinson and Company (BD) for the provision of BD Biosciences FACSCanto flow cytometry services. The contract has a ceiling value of $53,270.30 and a period of performance ending on September 30, 2027. This contract is not set aside for any specific business designation. BD, a large for-profit medical...

This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Becton, Dickinson And Company (BD) to provide a FACSCANTO II SYSTEM FLOW CYTOMETER and associated maintenance services. The contract is a firm-fixed-price order under BD's Multiple Award Schedule (MAS) contract with the General Services Administration (GSA), with a ceiling value of $64,908.00 and a period of performance through August 27, 2027. The contract does not have a set-aside designation. BD is a global...

This contract is for the provision of a FACSCalibur and a FACSAria flow cytometers and associated services by Becton, Dickinson and Company (BD) to the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services. The contract has a one-year period of performance with two optional one-year renewal periods. This is a firm-fixed price delivery order placed against BD's General Services Administration (GSA) Schedule 66 contract for...

Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, was awarded a $23,598 firm fixed-price purchase order for maintenance and support services on a Facsaria Fusion 2 laser system. The contract period runs from November 26, 2015, through November 25, 2016, with performance conducted in San Jose, California. Payment is structured as four equal quarterly installments of $5,899.50 each, with automatic payments made in arrears and no invoicing required. This award was...

This is a firm fixed-price delivery order under the Multiple Award Schedule (MAS) contract, awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson And Company (BD). The contract is for maintenance services on a FACS Canto flow cytometry machine used by the NHLBI Laboratory of Molecular Immunology for research purposes. The contract has a total ceiling value of $12,981.60 and a period of performance through...

This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is for maintenance services on a FACS Canto flow cytometry instrument used in research by the NHLBI Laboratory of Molecular Immunology. The contract has a firm fixed price ceiling of $12,981.60 and runs from December 1, 2024 to November 30, 2025. The contract was awarded under the Multiple...

Becton, Dickinson and Company, through its BD Biosciences division, was awarded a Purchase Order contract by the National Cancer Institute (NCI) on March 1, 2026, for FACSCanto Service Agreement with a ceiling value of $19,967.52. The contract, which utilizes Firm Fixed Price pricing and includes no small business set-aside, is scheduled for ultimate completion on February 28, 2027, with performance conducted in San Jose, California. This purchase order represents a service agreement for...

This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration to Becton, Dickinson and Company (BD) for preventive maintenance and repair services for a BD FACSAria Illu flow cytometer/cell sorter system. The contract has a ceiling value of $154,840.80 and a period of performance through September 7, 2030. BD is a large, established medical technology manufacturer that has a long history of federal contract awards, primarily for supplying flow cytometry...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD) for $221,224.92. The contract provides a 5-year full service agreement for BD FACS Canto, FACS Loader, and FACS Melody flow cytometry systems used by the NIH Clinical Center's Center for Cellular Engineering to support manufacturing of cell-based therapies. The contract includes preventive maintenance, emergency...